A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AMPT / alpha-methyl-p-tyrosine

[Related PubMed/MEDLINE]
Total Number of Papers: 218
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AMPT  (>> Co-occurring Abbreviation)
Long Form:   alpha-methyl-p-tyrosine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Hypoxia-Associated Changes in Striatal Tonic Dopamine Release: Real-Time in vivo Measurements With a Novel Voltammetry Technique. FSCV, MCSWV
2019 Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency. DA, SN, TH
2018 Evaluation of Anxiolytic and Antidepressant-like Activity of Aqueous Leaf Extract of Nymphaea LotusLinn. in Mice. BDNF, FST, MAO, OFT, PCPA, PRAZ, YOH
2018 Neural Correlates of Impaired Reward-Effort Integration in Remitted Bulimia Nervosa. fMRI, MID
2017 alpha-Methyltyrosine, a tyrosine hydroxylase inhibitor, decreases stress response in zebrafish (Danio rerio). ---
2017 Anxiolytic- and antidepressant-like activities of a methanolic extract of Morinda citrifolia Linn. (noni) fruit in mice: Involvement of benzodiazepine-GABAAergic, serotonergic and adrenergic systems. EPM, LDT, PCPA, TST
2017 Neural response to catecholamine depletion in remitted bulimia nervosa: Relation to depression and relapse. CBF, pCASL, pMCC
2016 Cardiac sympathetic activity in 22q11.2 deletion syndrome. 22q11.2DS, COMT, NE, WO
2016 Xylopia aethiopica fruit extract exhibits antidepressant-like effect via interaction with serotonergic neurotransmission in mice. 5-HT, FST, pCPA, TST, XAE
10  2015 Behavioral responses to catecholamine depletion in unmedicated, remitted subjects with bulimia nervosa and healthy subjects. BN, CD, rBN
11  2015 Phytotherapy of experimental depression: Kalanchoe integra Var. Crenata (Andr.) Cuf Leaf Extract. ANOVA, CNS, FST, TST
12  2014 Anxiolytic and antidepressant like effects of natural food flavour (E)-methyl isoeugenol. EPM, FST, LDB, MIE, OF, PCPA
13  2014 Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder. BPM, DAT, KD, WT
14  2014 Effects of catecholamines on thymocyte apoptosis and proliferation depend on thymocyte microenvironment. AR, ATOC, CA, TH
15  2014 Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors. DA, ISO, PA, PE
16  2014 Plurality of anxiety and depression alteration mechanism by oleanolic acid. BDNF, PCPA, PRAZ, PTZ
17  2014 Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis. DA, PPI, UHR
18  2014 The effects of catecholamine depletion on the neural response to fearful faces in remitted depression. CBF, DLPFC, FF, ITG, MDD, NF, PCC, RMDD
19  2014 The role of BDNF, leptin, and catecholamines in reward learning in bulimia nervosa. BDNF
20  2013 Angiotensin II Stimulates Sympathetic Neurotransmission to Adipose Tissue. Ang II, NE, NIS
21  2013 Antidepressive-Like Property of Dichloromethane Fraction of Pimenta pseudocaryophyllus and Relevance of Monoamine Metabolic Enzymes. DF, FS, MAO, OF, PCPA, TS
22  2013 Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [(18)F]fluorodeoxyglucose positron emission tomography study. MDD, OFC, PET
23  2013 Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study. BOLD, PLA, SCH
24  2013 Dopaminergic regulation of circadian food anticipatory activity rhythms in the rat. FEOs, SCN
25  2013 Growth hormone response to catecholamine depletion in unmedicated, remitted subjects with major depressive disorder and healthy controls. hGH, rMDD
26  2013 Reduction in total plasma ghrelin levels following catecholamine depletion: relation to bulimic and depressive symptoms. PYY, rBN
27  2013 Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis. UHR
28  2012 Dopamine-related deficit in reward learning after catecholamine depletion in unmedicated, remitted subjects with bulimia nervosa. BN, CD, HC, rBN
29  2012 Pharmacological mechanisms of antidepressant-like effect of tipepidine in the forced swimming test. PCPA
30  2012 The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge test. D2Rs, FD, HV, SPECT
31  2011 Antipsychotic-induced DRD2 upregulation and its prevention by alpha-lipoic acid in SH-SY5Y neuroblastoma cells. AP, DA
32  2010 In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations. VMAT2
33  2009 Impairments of probabilistic response reversal and passive avoidance following catecholamine depletion. CD, PA
34  2009 Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. PET
35  2009 Reward processing after catecholamine depletion in unmedicated, remitted subjects with major depressive disorder. MDD, MID, rMDD
36  2008 AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures. SPECT
37  2008 Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems. PCPA
38  2008 Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride. BP, DA, PET
39  2008 Polychlorinated biphenyl-induced oxidative stress in organotypic co-cultures: experimental dopamine depletion prevents reductions in GABA. DA, NAC, PCBs, VM, VMAT
40  2008 Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans. BP, PET
41  2008 The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. DA, METH, TH
42  2007 An intact dopaminergic system is required for context-conditioned release of 5-HT in the nucleus accumbens of postweaning isolation-reared rats. CER
43  2007 Challenge tests of monoaminergic systems: neurophysiological aspects. ---
44  2007 Constant illumination causes spatially discrete dopamine depletion in the normal and degenerate retina. ---
45  2007 Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. DA, NE, PCPA, TST
46  2007 Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats. ---
47  2007 Low dose alpha-methyl-para-tyrosine (AMPT) in the treatment of dystonia and dyskinesia. ---
48  2007 Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. APTD, ATD, DA, MDD, NE, PCPA
49  2007 The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. MDMA
50  2006 Dopamine-mediated actions of ephedrine in the rat substantia nigra. SNc
51  2006 Sex differences in depressive response during monoamine depletions in remitted depressive subjects. HAM-D
52  2006 Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT study. ARCI, DAI, POMS
53  2006 The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen. PD
54  2005 Effects of alpha-methyl-p-tyrosine on extracellular dopamine levels in the nucleus accumbens and the dorsal striatum of freely moving rats. DA
55  2005 Halothane enhances dopamine metabolism at presynaptic sites in a calcium-independent manner in rat striatum. CSF, DA, TTX
56  2005 The effect of endogenous dopamine in rotenone-induced toxicity in PC12 cells. DA, PD
57  2005 Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: cyp2d6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. ---
58  2004 Depletion and restoration of endogenous monoamines affects beta-CIT binding to serotonin but not dopamine transporters in non-human primates. L-5-HTP, L-DOPA, PCPA
59  2004 Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice. DA, MPTP, PD, TH
60  2004 Manganese-induced cytotoxicity in dopamine-producing cells. CATH.a, DA, Mn, NAC, PD
61  2003 Effects of catecholamine depletion on D2 receptor binding, mood, and attentiveness in humans: a replication study. DA, EBR, HVA, MHPG, NE, PET
62  2003 FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats. ---
63  2003 Monoamine depletion in psychiatric and healthy populations: review. APTD, ATD
64  2003 Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. NRIs, PET, SSRIs
65  2003 The effect of 3,4-methylenedioxymethamphetamine ('Ecstasy') on serotonergic regulation of the mammalian circadian clock mechanism in rats: the role of dopamine and hyperthermia. HAL, MDMA, SCN
66  2002 Dopamine depletion results in increased neostriatal D(2), but not D(1), receptor binding in humans. DA, PET
67  2002 Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity. DA, MDMA
68  2002 Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268. DA, DOI, mGlu
69  2002 Nitecapone and selegiline as effective adjuncts to L-DOPA in reserpine-induced catatonia in mice. ---
70  2001 A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. DA, PET
71  2001 Effects of alpha-methyl-para-tyrosine-induced catecholamine depletion in patients with seasonal affective disorder in summer remission. SAD
72  2001 Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity. DA, METH
73  2001 Prolonged inhibition of presynaptic catecholamine synthesis with alpha-methyl-para-tyrosine attenuates the circadian rhythm of human TSH secretion. TRH
74  2001 Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release. 5-HIAA, DOPAC, PCPA
75  2001 Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging. ---
76  2000 Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders. DA, DAT, SPECT
77  2000 Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting. MFB
78  2000 Endogenous dopaminergic tone and dopamine agonist action. L-dopa
79  2000 Prenatal cocaine exposure increases serotonergic inhibition of electrically evoked acetylcholine release from rat striatal slices at adulthood. DA, PCOC, pSAL
80  1999 Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder. ---
81  1999 Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder. OC, OCD
82  1999 Effects of dopamine on the in vivo binding of dopamine D2 receptor radioligands in rat striatum. BP, i.p
83  1999 Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders. D1R, D2R, DA, DAergic, DAT, IPD, PET, SPECT
84  1999 Regional distribution and control of tyrosine hydroxylase activity in the quail brain. TH
85  1999 The effect of presynaptic catecholamine depletion on 6-hydroxymelatonin sulfate: a double blind study of alpha-methyl-para-tyrosine. ---
86  1998 Dopamine receptor sensitive effect of dizocilpine on feeding behaviour. ACTH, EAAs
87  1998 Effects of lead exposure on GnRH and LH secretion in male rats: response to castration and alpha-methyl-p-tyrosine (AMPT) challenge. LH
88  1998 Monoamine dysfunction and the pathophysiology and treatment of depression. CNS, SSRIs
89  1998 Neuronal mechanisms of phencyclidine-induced place aversion and preference in the conditioned place preference task. CPP, DAergic
90  1998 Prolonged inhibition of presynaptic catecholamine synthesis does not alter leptin secretion in normal-weight men and women. MHPG, NE
91  1997 Carotid body dopamine content and release by short-term hypoxia: effect of haloperidol and alpha methyl paratyrosine. CB, D2's, DA, DACB
92  1997 Central noradrenergic & dopaminergic modulation of brewer's yeast-induced inflammation & nociception in rats. NA
93  1997 Effect of alpha-methyl-para-tyrosine on response to cocaine challenge. ---
94  1997 Imaging D2 receptor occupancy by endogenous dopamine in humans. BP, PET, SPECT
95  1997 Lack of behavioral effects of monoamine depletion in healthy subjects. ---
96  1997 Suppression of the rat micturition reflex by imipramine. HC-3, i.c.v, IMI, PCPA
97  1997 Threshold of dopamine content and D1 receptor stimulation necessary for the expression of rotational behavior induced by D2 receptor stimulation under normo and supersensitive conditions. EDA, HPLC, MFB, QA
98  1996 Bupropion induces sniffing: a possible dopaminergic mechanism. i.p
99  1996 Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. FLUOX, KET, MDMA, SAL, TEMP
100  1996 Effects of alpha-methyl-para-tyrosine (AMPT) in drug-free depressed patients. HDRS, HVA, MPHG, NE